SCHEMBL1490619

SCHEMBL1490619

COC(=O)c1c(NC(=O)OCc2ccccc2)csc1-c1cnc(OC)cn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
TACR3 P29371 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
PABPC1 P11940 1/20 0.39
POLB P06746 1/20 0.39
ROCK2 O75116 1/20 0.39
MAPK1 P28482 1/20 0.38
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
FAAH O00519 1/20 0.37
MGLL Q99685 1/20 0.37
ALDH1A1 P00352 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1490433 0.84 NPC1 (0.44) NPC1RAB9ATACR3SMN1; SMN2KMT2A
SCHEMBL1490674 0.83 NPC1 (0.42) NPC1RAB9ASMN1; SMN2KMT2AMEN1
SCHEMBL1490577 0.81 HDAC3 (0.45) NPC1RAB9ATACR3SMN1; SMN2POLB
SCHEMBL1490219 0.81 SMN1; SMN2 (0.41) NPC1RAB9ATACR3SMN1; SMN2KMT2A
SCHEMBL3555247 0.80 NPC1 (0.58) NPC1RAB9ATACR3SMN1; SMN2KMT2A
SCHEMBL1490684 0.77 NPC1 (0.52) NPC1RAB9ATACR3SMN1; SMN2KMT2A
SCHEMBL1490259 0.77 NPC1 (0.56) NPC1RAB9ASMN1; SMN2KMT2AMEN1
SCHEMBL1490425 0.76 RAB9A (0.48) NPC1RAB9ATACR3SMN1; SMN2KMT2A
SCHEMBL1490594 0.76 MGLL (0.52) NPC1RAB9ATACR3SMN1; SMN2KMT2A
SCHEMBL1490651 0.76 NPC1 (0.48) NPC1RAB9ASMN1; SMN2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 US disclosed
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 US disclosed
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 US disclosed
US-8618307-B2 Compounds that modulate intracellular calcium CALCIMEDICA, INC. (US) 2013-12-31 US disclosed
EP-2477982-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM Calcimedica, Inc. (US) 2012-07-25 EP disclosed
WO-2011034962-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2011-03-24 WO disclosed
WO-2011034962-A2 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2011-03-24 WO disclosed
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2011-03-17 US disclosed
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2011-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 NPC1 262/4885RAB9A 1174/4885TACR3 847/4885
US-20110065724-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 NPC1 262/4885RAB9A 1174/4885TACR3 847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.